
A recent report by the OECD shares concerns that the UK’s overall health looks set to face a crisis due …

Data from the Organisation for Economic Co-operation and Development (OECD) shows Korea and Israel are investing much more in research …

The high prices that pharma companies charge for specialty medicines are straining the health budgets of wealthy nations, according to …

NICE is updating its guidance in a bid to help doctors spot the signs and symptoms of cancer as part …

Clinical trials are an essential part of the development of medical treatments. They involve testing new medicines or new therapies, …
Growth in health spending slowed or fell in real terms in 2010 in almost all OECD countries, reversing a long-term …
The NHS in England does not perform well on some patient outcomes for cancer, stroke and respiratory diseases given the …
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns

